NMDAR1 autoantibodies as potential biomarkers for schizophrenia phenotyping.

MLA

Hansen, Niels, et al. “NMDAR1 Autoantibodies as Potential Biomarkers for Schizophrenia Phenotyping.” The Lancet. Psychiatry, vol. 11, no. 10, Oct. 2024, pp. 780–81. EBSCOhost, https://doi.org/10.1016/S2215-0366(24)00282-7.

APA

Hansen, N., Luedecke, D., Maier, H. B., Neyazi, A., Fitzner, D., Wiltfang, J., & Malchow, B. (2024). NMDAR1 autoantibodies as potential biomarkers for schizophrenia phenotyping. The Lancet. Psychiatry, 11(10), 780–781. https://doi.org/10.1016/S2215-0366(24)00282-7

Chicago

Hansen, Niels, Daniel Luedecke, Hannah Benedictine Maier, Alexandra Neyazi, Dirk Fitzner, Jens Wiltfang, and Berend Malchow. 2024. “NMDAR1 Autoantibodies as Potential Biomarkers for Schizophrenia Phenotyping.” The Lancet. Psychiatry 11 (10): 780–81. doi:10.1016/S2215-0366(24)00282-7.